Did you know early cancer detection can make a huge difference? SPOT-MAS is a groundbreaking, non-invasive test designed to detect five common cancers: lung, liver, breast, stomach, and colorectal cancer. Thanks to this advanced technology, cancer screening is now more convenient and accurate.

What is SPOT-MAS?
SPOT-MAS leverages Next Generation Sequencing (NGS) technology to detect circulating tumor DNA (ctDNA) from tumor cells. Through a single venous blood draw, it provides a comprehensive cancer risk overview. This fast, non-invasive test is ideal for individuals at high risk, such as smokers, alcohol consumers, or those exposed to harmful chemicals.

Why is Early Detection Important?
Early detection is crucial for increasing survival rates. Identifying cancer risks before symptoms appear enables quicker, more effective treatment. Instead of waiting for advanced symptoms, preventive measures can be taken sooner, providing hope and improving quality of life.

Who Should Take This Test?
SPOT-MAS is recommended for people aged 40 and above, especially those with risk factors like a family history of cancer, hepatitis B or C, or frequent exposure to hazardous chemicals. However, it’s not suitable for pregnant women or those who have recently undergone blood transfusions.

Benefits of SPOT-MAS
This highly accurate test offers unparalleled convenience. Without invasive procedures, it helps detect cancer risks early. Combined with other cancer screenings, SPOT-MAS is a vital step toward better health.

Reach out to SAPA PRAMITA at 0888 0305 7700 for any inquiries or further information. We're here to help!